Skip to main content
Indegene Limited logo

Indegene Limited — Investor Relations & Filings

Ticker · INDGN ISIN · INE065X01017 LEI · 335800XFEREFIW9LG995 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2025-08-01 Regulatory Filings
Country IN India
Listing BSE.NS INDGN

About Indegene Limited

https://www.indegene.com/

Indegene Limited provides digital-led commercialization services for the life sciences sector. The company integrates deep domain knowledge with proprietary technology platforms to assist biopharmaceutical, emerging biotech, and medical device organizations. Its core offerings span the entire product lifecycle, including clinical development support, regulatory compliance, pharmacovigilance, and multi-channel marketing operations. By leveraging artificial intelligence and machine learning, Indegene enables clients to optimize drug development processes, enhance patient engagement, and drive operational efficiencies. The company focuses on modernizing traditional commercial models through data-driven insights and digital transformation strategies, helping global healthcare organizations navigate complex regulatory environments and improve health outcomes through scaled, technology-enabled solutions.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short communication dated August 1, 2025, addressed to stock exchanges, providing a link to the audio recording of the Q1FY26 earnings call. It references SEBI regulations and states that the audio recording is for information and records. The document does not contain the transcript itself, financial data, or detailed analysis, but merely announces the availability of the earnings call recording. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is an announcement related to the earnings call but does not contain the call transcript or financial results itself. The document length is only 1347 characters, supporting that it is an announcement rather than a full report or transcript.
2025-08-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Interim / Quarterly Report Classification · 95% confidence The document is an analyst presentation and fact sheet on financial results for the quarter ended June 30, 2025 (Q1 FY26). It contains detailed financial highlights, business mix, segment performance, management commentary, and strategic initiatives. The content is comprehensive and includes actual financial data and analysis for the quarter, not just a brief announcement or a link to a report. The document is clearly a quarterly financial report with substantive financial data and management discussion. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2025-07-31 English
Monitoring Agency Report
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended June 30, 2025' and is issued pursuant to SEBI regulations related to the monitoring of IPO proceeds. It contains detailed financial and compliance information about the utilization of IPO proceeds, including tables of expenditure, deployment of unutilized proceeds, and certifications by a monitoring agency. The document is comprehensive and contains substantive financial data and analysis for a specific quarter, indicating it is a financial report for a period shorter than a full fiscal year. It is not an announcement or a brief summary but a detailed monitoring report as required by regulatory authorities. Therefore, it fits best under the category of an Interim / Quarterly Report (IR).
2025-07-31 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated July 31, 2025, announcing the financial results for the quarter ended June 30, 2025. It includes key financial highlights such as revenue, EBITDA, and profit margins for the quarter, along with commentary from the CEO and CFO. The document is approximately 5282 characters long, which is relatively short and primarily serves as an announcement rather than a detailed financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). Instead, it summarizes the financial results and strategic highlights, which aligns with the definition of an Earnings Release (ER). Therefore, the appropriate classification is Earnings Release (ER).
2025-07-31 English
ESOP/ESOS/ESPS
Regulatory Filings
2025-07-31 English
Outcome of Board Meeting
Regulatory Filings
2025-07-31 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.